Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 23.75p on 02-06-2026 at 17:25:11
Change -0.75p -3.06%
Buy 24.00p
Sell 23.50p
Last Trade: Buy 10,000.00 at 23.88p
Day's Volume: 1,195,745
Last Close: 23.75p
Open: 24.50p
ISIN: GB00B63D3314
Day's Range 23.75p - 24.50p
52wk Range: 7.90p - 27.80p
Market Capitalisation: £246.47m
VWAP: 23.89129p
Shares in Issue: 1.04b

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 10,000 23.88p Ordinary
16:29:53 - 02-Jun-26
Sell* 2,000 23.615p Ordinary
16:23:59 - 02-Jun-26
Sell* 400 23.615p Ordinary
16:20:36 - 02-Jun-26
Buy* 10,443 23.88p Ordinary
16:20:33 - 02-Jun-26
Buy* 9,526 24.00p Ordinary
16:19:01 - 02-Jun-26
Buy* 2,034 24.00p SI Trade
16:19:00 - 02-Jun-26
Sell* 121 23.50p SI Trade
16:19:00 - 02-Jun-26
Buy* 229 24.00p SI Trade
16:19:00 - 02-Jun-26
Buy* 4 24.00p SI Trade
16:19:00 - 02-Jun-26
Sell* 1,710 23.6378p Ordinary
16:18:36 - 02-Jun-26
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
1st Jun 2026 (Mon) 24.00 24.75 24.00 24.50 1,928,027
29th May 2026 (Fri) 24.50 24.50 23.90 23.90 1,074,436
28th May 2026 (Thu) 24.50 24.50 23.75 24.50 1,298,230
27th May 2026 (Wed) 23.00 24.75 23.00 24.50 2,588,324
26th May 2026 (Tue) 22.00 23.25 22.00 23.00 1,485,525
25th May 2026 (Mon) 22.00 22.00 22.00 22.00 0
22nd May 2026 (Fri) 21.00 22.60 22.00 22.00 1,545,941
21st May 2026 (Thu) 20.50 21.60 21.00 21.00 4,252,809
20th May 2026 (Wed) 26.50 26.50 20.25 20.50 12,503,840
19th May 2026 (Tue) 25.25 27.80 25.00 26.50 11,299,996
18th May 2026 (Mon) 22.50 25.00 22.50 25.00 8,432,841
15th May 2026 (Fri) 21.00 22.75 21.50 22.75 3,976,208
14th May 2026 (Thu) 20.25 21.50 20.80 21.00 4,397,659
13th May 2026 (Wed) 18.25 20.25 18.90 20.00 2,140,991
12th May 2026 (Tue) 18.50 19.00 18.25 18.50 1,328,577
11th May 2026 (Mon) 17.00 19.25 17.20 19.00 3,529,558
8th May 2026 (Fri) 16.75 17.00 16.75 17.00 1,625,383
7th May 2026 (Thu) 15.75 16.50 16.25 16.50 1,979,777
6th May 2026 (Wed) 16.25 16.25 15.75 15.75 1,359,502
5th May 2026 (Tue) 15.25 16.25 15.50 16.25 4,044,272
4th May 2026 (Mon) 15.10 15.10 15.10 15.10 0
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
28th Apr 2026 7:00 am RNS FDA Fast Track Designation for iSCIB1+
2nd Apr 2026 7:00 am RNS Scancell announces CFO transition
29th Jan 2026 7:00 am RNS Half-year Financial Report
26th Jan 2026 7:00 am RNS FDA clearance of IND application for iSCIB1+
22nd Jan 2026 7:00 am RNS Notice of Results
9th Dec 2025 7:00 am RNS Continued improvement in PFS with iSCIB1+
7th Nov 2025 7:00 am RNS Research Update
30th Oct 2025 3:30 pm RNS Result of AGM
3rd Oct 2025 7:00 am RNS Notice of AGM
16th Sep 2025 7:00 am RNS Director Dealing
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

WINNERS & LOSERS: Indonesia curbs hit MP Evans; S&U rises

20th May 2026 10:00

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

TRADING UPDATES: Conduit CFO Whelan to step down in September

28th Apr 2026 17:19

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Scancell names David Schilansky as interim finance chief

2nd Apr 2026 14:28

Scancell Holdings PLC - Oxford-based pharmaceutical company focused on cancer immunotherapies - Appoints "highly experienced senior healthcare executive and entrepreneur" David Schilansky, effective immediately, as a financial advisor. Says he will also become interim chief financial officer "later in April". Adds that it has launched a global recruitment process for a permanent successor to current CFO Sath Nirmalananthan, who is leaving Scancell and stepping down from the board with effect from April 24, "to pursue other professional opportunities." Scancell says Schilansky is currently concluding his role as chief executive officer of Ariceum Therapeutics, and starting as a venture partner and entrepreneur-in-residence at Redmile Group. Read More

EARNINGS AND TRADING: Pinewood Tech gets bid approach from Apax

29th Jan 2026 22:00

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial

26th Jan 2026 19:18

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

See more Scancell Holdings news
FTSE 100 Latest
Value10,373.51
Change34.56

Login to your account

Forgot Password?

Not Registered